Zaraki Kenpachi
When the Biden administration, in a surprise reversal, announced this week that it would support the waiver of intellectual property rights connected to Covid-19 vaccines, the announcement was hailed as a huge step in the fight to contain the global Covid pandemic, with the head of the World Trade Organization (WTO) calling it a “monumental moment in the fight against Covid-19.”
For many, it sparked hopes that vaccine manufacturers around the world would soon be able to begin making copies of the various Covid vaccines, expanding supply at a time when the vast majority of the world’s population remains unvaccinated…
Hugh Hay
